HSP90B1 is proposed to be associated with poor survival from hepatocellular carcinoma (HCC), whereas high levels of HSPA5 and HSPA6 may be associated with earlier recurrence of HCC [29]. The gene discussed is HSPA5; the disease is hepatocellular carcinoma.